Core Insights - The second half of 2025 begins with cautious optimism in U.S. stock markets, despite ongoing geopolitical tensions, particularly between the U.S. and China, which are affecting the global economic outlook [1] - The S&P 500, Nasdaq Composite, and Dow Jones Industrial Average all recorded modest gains, indicating a resilient market environment [2] Value Investing Appeal - Rising uncertainty in the market enhances the attractiveness of value investing strategies, particularly using the Price to Cash Flow (P/CF) ratio as a key valuation metric [3][9] - The P/CF ratio is favored over the Price/Earnings (P/E) ratio as it reflects a company's financial health by accounting for non-cash charges [4][5] Selection Criteria for Value Stocks - Effective value investing requires a comprehensive approach, considering multiple metrics such as price-to-book ratio, price-to-earnings ratio, and price-to-sales ratio, alongside a favorable Zacks Rank and Value Score [7][11] - Parameters for selecting true-value stocks include P/CF less than or equal to the industry median, a minimum stock price of $5, and an average 20-day trading volume exceeding 100,000 [8][10] Featured Value Stocks - StoneCo Ltd. (STNE) has a Zacks Rank of 1, with a trailing four-quarter earnings surprise of 6.4% and projected sales and EPS growth of 10.9% and 5.9%, respectively [12][13] - Centene Corporation (CNC) holds a Zacks Rank of 2, with a trailing earnings surprise of 25.5% and expected sales and EPS growth of 10.2% and 1.4%, respectively [13] - CVS Health Corporation (CVS) also has a Zacks Rank of 2, showing a trailing earnings surprise of 18.1% and projected sales and EPS growth of 3.5% and 12.6%, respectively [14] - Pfizer Inc. (PFE) carries a Zacks Rank of 2, with a trailing earnings surprise of 43.5% but expected declines in sales and EPS of 0.6% and 1.6%, respectively [15]
Top 4 Value Stocks to Buy as Trade Tensions Still Cloud H2 Outlook